EP3141275A1 — Medicament delivery device
Assigned to Carebay Europe Ltd · Expires 2017-03-15 · 9y expired
What this patent protects
The present invention relates to a medicament delivery comprising a housing (10; 100), which housing (10; 100) is arranged to accommodate a medicament container (18; 108), a drive mechanism (34; 116) capable of, upon activation, act on said medicament container (18; 108), a commu…
USPTO Abstract
The present invention relates to a medicament delivery comprising a housing (10; 100), which housing (10; 100) is arranged to accommodate a medicament container (18; 108), a drive mechanism (34; 116) capable of, upon activation, act on said medicament container (18; 108), a communication unit (60; 160) arranged in said housing (10; 100), a switch (58; 144) operably connectable to said drive mechanism (34; 116) and connected to said communication unit (60; 160) for activating said communication unit (60; 160) when operated, wherein said switch (58; 144) is operated by said drive mechanism (34; 116) at the end of a dose delivery sequence.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.